Detail Information
Publications
A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitusJacob Hyllested-Winge
Novo Nordisk A S, Virum, Denmark
Clin Drug Investig 30:643-74. 2010..Together, the benefits of NovoPen are considered likely to improve both patients' quality of life and their compliance with therapy...
